Medicover AB Class B

Medicover AB Class B

28.25
USD
+1.00
(+3.67%)
0.65EPS
Feb 10Next Earn

Important Dates

Medicover AB's next confirmed earnings release is scheduled for February 10, 2027.

Earnings Date2/10/2027

Share Statistics

As of September 30, 2026, Medicover AB has 151.97M shares outstanding.

Shares Outstanding151.97M

Financial Position

As of September 30, 2026, Medicover AB maintains a current ratio of 0.75, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 226.27, indicating elevated leverage, while an interest coverage ratio of 6.43 demonstrates adequate ability to service its debt obligations.

Current Ratio0.75
Quick Ratio0.08
Debt / Equity226.27
Debt / EBITDA3.13
Interest Coverage6.43

Financial Efficiency

USD

These figures cover the twelve months ended September 30, 2026. The company generates approximately 58,691.94 in revenue per employee across its workforce of 47,256.00, a quick read on workforce productivity versus industry peers.

Revenue Per Employee58,691.94
Employee Count47,256.00

Taxes

USD

Over the twelve months ended September 30, 2026, Medicover AB recorded 33.32M in income tax expense. That works out to an effective tax rate of 25.34, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 131.47M, leaving 103.25M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax33.32M
Effective Tax Rate25.34

Stock Price Statistics

As of the close on November 2, 2026, Medicover AB's stock has gained approximately 3.67% over the past 52 weeks.

52-Week Price Change3.67%

Income Statement

USD

Over the twelve months ended September 30, 2026, Medicover AB generated 2.77B in revenue and converted that into 103.25M in net income, yielding earnings per share of 0.65. EBITDA reached 456.87M, while operating income came in at 206.73M.

Revenue2.77B
Gross Profit656.47M
Operating Income206.73M
Pretax Income131.47M
Net Income103.25M
EBITDA456.87M
EBIT206.73M
Earnings Per Share (EPS)0.65

Balance Sheet

USD

As of September 30, 2026, Medicover AB holds 97.47M in cash and equivalents against 1.43B in total debt, resulting in a net debt position of 856.96M. Total book value stands at 611.58M, with working capital of -307.15M providing operational flexibility.

Cash & Cash Equivalents97.47M
Total Debt1.43B
Net Debt856.96M
Equity (Book Value)611.58M
Book Value Per Share4.02
Working Capital-307.15M

Cash Flow

USD

Medicover AB produced 385.58M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -164.46M in capital expenditures, free cash flow totaled 221.13M - equivalent to 1.46 per share.

Operating Cash Flow385.58M
Capital Expenditures-164.46M
Free Cash Flow221.13M
FCF Per Share1.46

Margins

Over the twelve months ended September 30, 2026, Medicover AB posted a gross margin of 23.67, reflecting its pricing power and cost economics. The operating margin of 7.45 and net profit margin of 3.72 provide insight into operational efficiency.

Gross Margin23.67
Operating Margin7.45
Pretax Margin4.74
Profit Margin3.72
EBITDA Margin16.47

Dividends & Yields

USD

Over the twelve months ended September 30, 2026, Medicover AB paid dividends of 0.23 per share. The dividend payout ratio of 36.61 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.

Dividend Per Share0.23
Payout Ratio36.61